跳至主要内容
临床试验/NCT06421116
NCT06421116招募中不适用

Validation of a Preclinical Model Based on Patient-derived Organoids for the Study of the Gut-joint Axis in Spondyloarthritis

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年3月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Viability assessment

研究概览

简要总结

This project aims to develop and validate a model of human organoids derived from patients with Spondyloarthritis, focusing on synovial and intestinal tissues as targets of the gut-joint axis. The tissue marker profile of patient-derived organoids studied by gene expression, immunohistochemistry, and cytokine production profile will be compared with that of controls in order to test for the presence of specific biomarkers.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • More than 18 years of age;
  • Ability to understand and sign an informed consent form;
  • Clinical indication for intestinal and/or synovial biopsy;
  • Only for SpA patients group: meeting ASAS classification criteria.

排除标准

  • Actively treated cancer;
  • Severe comorbidities that, in the investigator's opinion, may affect the quality of samples for planned experimental applications;
  • Only for patients undergoing ileal-colic biopsy: history of colorectal cancer disease, celiac disease;
  • Only for patients undergoing a synovial biopsy: septic arthritis.

结局指标

主要结局

Viability assessment

时间窗: 24 months

The viability of organoids will be determined using an adenosine triphosphate (ATP) detection assay based on luminescence using a commercially available luciferase.

次要结局

  • Production of pro-inflammatory cytokines(24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Validation of a Preclinical Model Based on... | 临床试验